Company intelligence / Profile preview
Innolake Biopharm
Hangzhou, Zhejiang, Chinainnolakebio.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Innolake Biopharm is a clinical-stage biotech focused on innovative medicines for cancer and autoimmune diseases. Its pipeline includes first-in-class/best-in-class monoclonal antibodies, small molecules, and ADCs. Three programs have entered or are entering clinical trials as of May 2024. Notably, ILB‑3101 is the world’s first anti-B7H3 ADC with Eribulin payload to enter human studies; other assets target A2aR and CD40 pathways. The company emphasizes rapid R&D progression from candidate selection to IND filing within one year for some projects
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodies (mAbs)Small moleculesAntibody-drug conjugates (ADCs)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
WuXi Biologics’ industry investment fund participated as an investor; no major disclosed pharma co-development partnerships yet.
Beyond the preview
Go deeper on Innolake Biopharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innolake Biopharm.